International Conference «Trusted Evidence for Better Health: Achievements and Barriers» (QiQUM 2025) QiQUM – Quality information for Quality Use of Medicines 4-5 December 2025 Russian Medical Academy of Continuous Professional Education (RMANPO), MoscowDear Colleagues and Friends, 

Catherine Spencer OBE, who served as the Cochrane Collaboration’s Chief Executive Officer since 2022, has decided to step down from the role.Catherine has led Cochrane through transformational change, developing a new strategy for a more evidence-informed world and ensuring the organization is well-placed to deliver it. She has helped to cement Cochrane’s reputation as a world-leading source of trustworthy evidence and expand the charity’s reach and impact around the world.

March 2025 marks the third anniversary of Cochrane’s commitment to Public Involvement in Health and Social

A new Cochrane review has found evidence that music-based therapy may benefit people living with dementia, particularly by improving symptoms of depression. 

International Journal of Risk & Safety in Medicine (IJRSM) Call for Papers for a Special Issue on Trusted Evidence for Better Health: achievements and barriersSubmit before June 1, 2025We invite you to submit a manuscript for consideration in a special issue titled, Trusted Evidence for Better Health: Achievements and Barriers. This issue will publish materials from the International Conference "Trusted Evidence for Better Health: achievements and barriers (QiQUM 2025).

We are delighted to announce a new, joint Methods Group between the Cochrane Collaboration, the

We are pleased to announce that earlier this week, Cochrane’s status as a non-State actor (NSA) in official relations with the World Health Organization (WHO) was renewed at the 156th session of the WHO Executive Board meeting in Geneva.

Honouring Cochrane's Volunteer Translators: Bridging Language Gaps in 2024Cochrane proudly celebrates the incredible efforts of our volunteer translators in 2024. Their dedication has been instrumental in breaking language barriers and making high-quality health information accessible to communities worldwide.

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

Cochrane peer reviewers can now feature their peer review activity on their Web of Science profiles thanks to a new collaboration between Cochrane and Clarivate.